Initial lessons from public-private partnerships in drug and vaccine development.

@article{Wheeler2001InitialLF,
  title={Initial lessons from public-private partnerships in drug and vaccine development.},
  author={Colin Wheeler and Seth Berkley},
  journal={Bulletin of the World Health Organization},
  year={2001},
  volume={79 8},
  pages={728-34}
}
In recent years, venture capital approaches have delivered impressive results in identifying and funding promising health discoveries and bringing them to market. This success has inspired public sector experiments with "social venture capital" approaches to address the dearth of affordable treatment and prevention for diseases of the developing world. Employing the same focus on well-defined and measurable objectives, and the same type of connections to pool and deploy resources as their for… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Seeking innovation: incentive funding for biodefense biotechs.

Biosecurity and bioterrorism : biodefense strategy, practice, and science • 2010

References

Publications referenced by this paper.
Showing 1-5 of 5 references

The pharmacoeconomics of TB drug development. New York, Global Alliance for TB Drug Development (in press)

L. Nelson
Global Alliance for TB Drug Development. Scientific blueprint for TB drug development. Tuberculosis, • 2001

Venturing into funds

K. Gopal
Pharmaceutical Executive, • 1999

Similar Papers

Loading similar papers…